Chemed (NYSE:CHE) reported quarterly earnings of $6.42 per share which missed the analyst consensus estimate of $7.07 by 9.16 percent. This is a 6 percent decrease over earnings of $6.83 per share from the same period last year. The company reported quarterly sales of $639.337 million which missed the analyst consensus estimate of $659.085 million by 3.00 percent. This is a 0.10 percent decrease over sales of $639.993 million the same period last year.